Publications
June 14, 2024
CD37 is a Relevant Target for AML and MDS Treatment with Debio 1562M Antibody Drug Conjugate (ADC)
December 10, 2023
Debio 1562M, a next generation Antibody Drug Conjugate (ADC) targeting CD37 for AML and MDS treatment
November 13, 2023
The Multilink(TM) Linker is a promising approach to improve efficacy and safety of ADC’s